The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Vaccine

• Publication date

  2006-11-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2006.05.040PMID 16839650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Influenza Vaccine Formulation with a Detailed Analysis of the Cytokine Response

  2006cited by this paper
• Two Doses of Parenterally Administered Split Influenza Virus Vaccine Elicited High Serum IgG Concentrations which Effectively Limited Viral Shedding upon Challenge in Mice

  2005cited by this paper
• Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

  2005cited by this paper
• Cell biology of antigen processing in vitro and in vivo.

  2005cited by this paper
• Direct Cross-Priming by Th Lymphocytes Generates Memory Cytotoxic T Cell Responses1

  2005cited by this paper
• Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice

  2005cited by this paper
• Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

  2004cited by this paper
• Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract1

  2004cited by this paper
• Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation.

  2004cited by this paper
• Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.

  2003cited by this paper
• Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

  2003cited by this paper
• Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

  2002cited by this paper
• Virosome-mediated delivery of protein antigens to dendritic cells.

  2002cited by this paper
• Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.

  2001cited by this paper
• Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

  2001cited by this paper
• Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes.

  2000cited by this paper
• High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults

  1994cited by this paper
• Immunoglobulin A mediation of murine nasal anti-influenza virus immunity

  1991cited by this paper
• Passive transfer of local immunity to influenza virus infection by IgA antibody.

  1991cited by this paper

• Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques

  2022cites this paper
• Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program

  2020cites this paper
• How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions

  2019cites this paper
• Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.

  2019cites this paper
• Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy

  2018cites this paper
• Sex bias in mouse humoral immune response to influenza vaccine depends on the vaccine type.

  2018cites this paper
• Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate

  2017cites this paper
• Single immunization with MF59-adjuvanted inactivated whole-virion H7N9 influenza vaccine provides early protection against H7N9 virus challenge in mice.

  2017cites this paper
• Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus.

  2017cites this paper
• Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.

  2017cites this paper
• Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.

  2016cites this paper
• Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.

  2014cites this paper
• Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses.

  2014cites this paper
• qualene-adjuvanted H 7 N 9 virus vaccine induces robust humoral mmune response against H 7 N 9 and H 7 N 7 viruses hia

  2014cites this paper
• Animal Models of Prophylaxis and Prevention of Schizophrenia: Prenatal Seasonal Influenza Vaccine and Postnatal Valproate

  2012cites this paper
• Adjuvant effect of docetaxel on the immune responses to influenza A H1N1 vaccine in mice

  2012cites this paper
• Effects of Different Adjuvants in the Context of Intramuscular and Intranasal Routes on Humoral and Cellular Immune Responses Induced by Detergent-Split A/H3N2 Influenza Vaccines in Mice

  2011cites this paper
• Comparative safety, immunogenicity, and efficacy of several anti‐H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine)

  2011cites this paper
• Effects of UVA irradiation, aryl azides, and reactive oxygen species on the orthogonal inactivation of the human immunodeficiency virus (HIV-1).

  2011cites this paper
• Effects of different adjuvants in the context of intramuscular and intranasal routes on

  2011cites this paper
• Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re.

  2010cites this paper
• Immunopathology and Infectious Disease Human and Avian Influenza Viruses Target Different Cells in the Lower Respiratory Tract of Humans and Other Mammals

  2010cites this paper
• Preparing for an influenza pandemic: Re-evaluating the use of the whole inactivated virus vaccine formulation

  2009cites this paper
• Preparing for an influenza pandemic : Re-evaluating the use of the whole inactivated virus vaccine formulation –

  2009cites this paper
• Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities

  2008cites this paper
• Cross‐neutralisation of antibodies elicited by an inactivated split‐virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains

  2007cites this paper
• Development of stable influenza vaccine powder formulations for non-parenteral dosage forms: challenges and possibilities

  2007cites this paper
• Intranasal delivery of whole influenza vaccine prevents subsequent allergen‐induced sensitization and airway hyper‐reactivity in mice

  2007cites this paper
• The development of stable influenza vaccine powder formulations for new needle-free dosage forms

  2007cites this paper